Ειδήσεις: DRUG DEVELOPMENT | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 15:54 yahoo.com

Immunic appoints biopharmaceutical executive Jon Congleton to board

Immunic Jon Congleton biopharmaceutical board appointment drug development regulatory affairs

31/03 15:01 investing.com

Agios stock surges on FDA path for mitapivat approval

Agios Pharmaceuticals mitapivat FDA approval stock surge rare metabolic disorders investor confidence

31/03 14:34 yahoo.com

Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment

Amylyx Avexitide Phase 3 Lucidity Trial Acute Myeloid Leukemia enrollment

31/03 11:30 statnews.com

STAT+: Over-the-top psychedelic promos could undermine the field’s drug development efforts

psychedelic drugs drug development marketing FDA Helus Pharma mental health

30/03 17:06 github.io

Pharma is dosing drugs wrong – the quantum tunneling correction nobody is using

quantum tunneling pharmaceutical dosing pharmacokinetics drug safety dosing accuracy computational chemistry

30/03 17:00 entrepreneur.com

Pharma Giant Eli Lilly Is Paying $2.75 Billion for Drugs Designed by AI – Here’s What It Gets Them

Eli Lilly AI drug design pharmaceutical acquisition research acceleration biotech investment drug development

30/03 16:55 investing.com

Insmed stock gains on UTHR trial read-through, Morgan Stanley upgrade

Insmed UTHR trial Morgan Stanley stock upgrade urea cycle disorders biotech

29/03 23:42 yahoo.com

Why Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings

Aardvark Therapeutics ARD‑101 cardiac safety trial pause late‑stage trial biotech

29/03 15:50 google.com

Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly - Reuters

POLITICS

29/03 15:50 google.com

Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly - Reuters

POLITICS

Loading...